Form 8-K - Current report:
SEC Accession No. 0001104659-20-106112
Filing Date
2020-09-17
Accepted
2020-09-17 16:16:02
Documents
3
Period of Report
2020-09-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2030959d1_8k.htm 8-K 24343
2 EXHIBIT 99.1 tm2030959d1_ex99-1.htm EX-99.1 5678
3 GRAPHIC image_001.jpg GRAPHIC 4389
  Complete submission text file 0001104659-20-106112.txt   37624
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 201181373
SIC: 2834 Pharmaceutical Preparations